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et al., 1996; Miyazaki et al., 1996). In vitro, DM is sufficient
to release CLIP peptides from class II molecules, but
this effect is not restricted to CLIP (Sloan et al., 1995;
Monika Liljedahl,*§ Ola Winqvist,*§ Charles D. Surh,²
Phillip Wong,³ Karen Ngo,* Luc Teyton,²
Per A. Peterson,* Anders Brunmark,*
Weber et al., 1996; Kropshofer et al., 1997). Thus, theAlexander Y. Rudensky,³ Wai-Ping Fung-Leung,*
dissociation rate of any peptide from class II moleculesand Lars Karlsson*‖
appears to be increased in the presence of DM but*The R. W. Johnson Pharmaceutical Research Institute
remains proportional to the intrinsic dissociation rate of3535 General Atomics Court, Suite 100
the peptide (Weber et al., 1996; Kropshofer et al., 1997).San Diego, California 92121
Whether DM-mediated release of peptides other than²Department of Immunology
CLIP is also important in vivo is presently unknown.The Scripps Research Institute
In B cells, the majority of DM is associated with HLA-10550 North Torrey Pines Road
DO (DO) (Liljedahl et al., 1996), and a recent report hasLa Jolla, California 92037
shown that association with DO inhibits the ability of³Howard Hughes Medical Institute
DM to release CLIP, both in vitro and in transfectedUniversity of Washington
cells (Denzin et al., 1997). The physiological relevanceSeattle, Washington 98195
of this effect is unclear, however, since CLIP-containing
class II molecules are not particularly prominent on B
cellsÐthe main, if not exclusive, cell type expressing DOSummary
(Tonelle et al., 1985; Wake and Flavell, 1985; Karlsson
et al., 1991; Liljedahl et al., 1996; Douek and Altmann,HLA-DM catalyzes the release of MHC class II±asso-
1997).ciated invariant chain±derived peptides (CLIP) from
In contrast to dendritic cells, which are comitted toclass II molecules. Recent evidence has suggested
antigen presentation irrespective of antigen specificitythat HLA-DO is a negative regulator of HLA-DM in B
(Cella et al., 1997), B cells are themselves antigen spe-
cells, but the physiological function of HLA-DO re- cific, but usually require T cell help in order to mature
mains unclear. Analysis of antigen presentation by B into antibody-secreting plasma cells (Vitetta et al., 1991).
cells from mice lacking H2-O (the mouse equivalent The antigens presented by Bcells are internalized mainly
of HLA-DO), together with biochemical analysis using by their membrane immunoglobulin receptors (mIg)
purified HLA-DO and HLA-DM molecules, suggests (Rock et al., 1984; Lanzavecchia, 1985); receptor-inde-
that HLA-DO/H2-O influences the peptide loading of pendent antigen presentation by B cells, though well
class II molecules by limiting the pH range in which studied in vitro, is relatively inefficient. How B cells focus
HLA-DM is active. This effect may serve to decrease antigen presentation to antigens internalized by the B
the presentation of antigens internalized by fluid- cell receptor is unclear, since increased antigen capture
phase endocytosis, thus concentrating the B cell± can only partly explain this phenomenon (Watts, 1997).
mediated antigen presentation to antigens internal- It has been suggested that efficient B cell receptor±
ized by membrane immunoglobulin. mediated antigen presentation may require specialized
loading compartments (Mitchell et al., 1995; Watts,
1997), and several groups have described class II±rich
Introduction intracellular compartments (Peters et al., 1991; Amigor-
ena et al., 1994; Tulp et al.,1994; Westet al., 1994). These
Immediately after synthesis in the endoplasmic reticu- compartments are not restricted to B cells, however
lum (ER), major histocompatibility complex (MHC) class (Calafat et al., 1994; Kleijmeer et al., 1994), and their
II molecules associate with the invariant chain (Ii). Ii functional importance is unclear. Although the general
inhibits the binding of peptides and nascent proteins machinery for antigen processing is likely to be the same
to class II molecules in the ER and directs Ii±class II in different antigen-presenting cells, it is still possible
complexes to the endosomal system, where binding of that cell type±specific differences in antigen processing
antigenic peptides occurs (Wolf and Ploegh, 1995). Ii is may contribute to the efficient presentation of antigens
degraded by proteolysis, but complete removal of class internalized by mIg.
II±associated invariant chain peptides (CLIP) requires We generated mice lacking H2-Oa to evaluate the
the catalytic function of HLA-DM (DM), a resident of the importance of H2-O/DO for peptide loading and antigen
presentation. Cells from H2-Oa±deficient mice wereendosomal/lysosomal system that is structurally related
found to have normal levels of class II expression, andto class II molecules (Fling et al., 1994; Karlsson et al.,
the density of H2-Ab±CLIP complexes at the cell surface1994; Morris et al., 1994; Sanderson et al., 1994). The
was the same as in wild-type controls. However, B cellsabsence of DM (or H2-M, the equivalent mouse mole-
from H2-Oa±deficient mice were found to have changedcule) leads to the accumulation of CLIP-containing class
capacity to present protein antigens when compared toII molecules and decreased loading of antigenic pep-
B cells from wild-type mice, suggesting that the absencetides (Mellins et al., 1990; Fung-Leung et al., 1996; Martin
of H2-O does modify the peptide content of class II
molecules at the cell surface, either qualitatively or§These authors contributed equally to this work.
quantitatively. In older H2-Oa±deficient mice, serum lev-‖ To whom correspondence should be addressed (e-mail: lkarlsso@
prius.jnj.com). els of immunoglobulin G1 (IgG1) were elevated, further
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Figure 1. Disruption of the Mouse H2-Oa Gene
(A) The mouse H2-Oa gene and the knockout construct are shown. A neomycin-resistance gene (neo) was inserted into exon 2 of the H2-Oa
gene, and a herpes simplex±thymidine kinase gene (tk) was placed at the 39 end of the construct. Restriction sites are BamHI (B), EcoRI (E),
HindIII (H), NotI (N), SfiI (Sf), and SmaI (Sm). Numbered filled boxes are exons. The probes shown flanking the 59 and 39 ends of the construct
were used in Southern hybridization to confirm homologous recombinations.
(B) Immunoprecipitation from 35S-labeled spleen cells. H2-Oa1/1 (top) or H2-Oa2/2 (bottom) splenocytes were labeled for 30 min (a and c) and
either analyzed immediately (0 min) or after chase in nonradioactive medium for 240 min (b and d). H2-Ob was immunoprecipitated from the
cell lysates with rabbit antiserum K535 (anti-H2-Ob) andanalyzed by two-dimensional gel electrophoresis. Oap and Obp indicatenontransported
forms of Oa and Ob. Acidic proteins are located to the right.
(C) Confocal images of H2-Oa1/1 (a and b) or H2-Oa2/2 (c and d) splenocytes stained with K535 (a and c) and 2E5A (anti-H2-M) (b and d).
(D) Analysis of H2-O and H2-M expression by flow cytometry. B cells from H2-Oa1/1 (fine line) or H2-Oa2/2 (bold line) mice were permeabilized
with saponin and stained with 2E5A for H2-M (a) or K535 for H2-Ob (b). The negative control staining (dotted line) was the same in the two
types of mice.
suggesting that T cell±B cell interaction may be changed Results
in these mice. Analysis of DO function in vitro, using
Generation and Characterizationrecombinant molecules, confirmed the finding by Denzin
of H2-Oa±Deficient Miceet al. (1997) that DO inhibits DM function, but showed
Embryonic stem cells lacking a functional H2-Oa genethat the inhibition is decreased at an acidic pH, sug-
were generated by homologous recombination, as out-gesting that peptide loading may be favored in acidic
compartments (probably lysosomes) in the presence lined in Figure 1A. The disruption of the H2-Oa gene
was confirmed by Southern blotting. The modified em-of DO.
Together, our data suggest that DO/H2-O is a pH- bryonic stem cells were used to derive homozygous
mice in which both of the H2-Oa alleles were disrupted.dependent inhibitor of DM/H2-M, and that the main in-
fluence of DO/H2-O expression in vivo may not be to To confirm the absence of H2-Oa protein, splenocytes
from wild-type mice (H2-Oa1/1) or from H2-Oa±deficientdecrease CLIP release but rather to modify the peptide-
editing function of DM, probably by restricting the lo- mice (H2-Oa2/2) were metabolically labeled for 30 min,
and H2-O was immunoprecipitated using an H2-Ob anti-cation where DM is fully active. This action may serve
to focus antigen presentation to antigens internalized serum, either directly or after a 4 hr chase in nonradioac-
tive medium. In the absence of H2-Oa, the H2-Ob chainby mIg.
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Figure 2. Characterization of MHC Class II
Expression inH2-Oa2/2 Miceand H2-O1/1 Lit-
termates
(A) Lymph node cells from wild-type (shaded
area), H2-Oa2/2 (solid line),and H2-M2/2 (dot-
ted line) mice were stained with antibodies
reactive to H2-Ab (Y3P) or CLIP-containing
H2-Ab (30-2 and 15G4) and analyzed by flow
cytometry.
(B) Serial spleen sections from wild-type, H2-
Oa2/2, and H2-M2/2 mice were stained for
H2-O or H2-M with rabbit antiserum K535 or
K553, respectively. Locations of follicles (f),
periarteriolar lymphocyte sheath (pals), and
germinal centers (gc) are depicted.
(C) Immunoprecipitation from 35S-labeled
spleen cells. H2-Oa1/1 (left) or H2-Oa2/2
(right) splenocytes were labeled for 30 min
and then either analyzed immediately (0 min)
or after chase in nonradioactive medium for
the indicated time (in hours). H2-Ab was im-
munoprecipitated and samples were ana-
lyzed without prior boiling or reduction. Size
markers (at left) are in kilodaltons.
had a decreased half-life and did not associate with changed, so that the vast majority of molecules contain
CLIP. The class II expression at the cell surface of lymphH2-M or acquire any carbohydrate modifications, indi-
cating that it was not transported out of the ER (Figure node cells from H2-Oa±deficient mice was analyzed by
flow cytometry. As controls, cells from wild-type and1B). Indirect immunofluorescence staining of H2-Oa1/1
splenocytes with the H2-Ob antiserum showed the ex- H2-M±deficient mice were analyzed. The density of H2-
Ab expression on H2-Oa2/2 lymph node cells (whichcon-pected vesicular staining pattern (Liljedahl et al., 1996)
(Figure 1Ca), whereas the staining in H2-Oa2/2 B cells tain both B and T cells) was found to be similar to the
density on wild-type cells, whether thecells were restingwas barely detectable (Figure 1Cc). Staining with an H2-
M±reactive monoclonal antibody (mAb) showed that this or had been activated by treatment with lipopolysaccha-
ride (LPS) and interleukin-4 (IL-4). Thus, mAbs that bindmolecule had the same distribution whether or not H2-O
was present (compare Figures1Cb and 1Cd). Analysisof to H2-Ab irrespective of the bound peptides, such as
permeabilized B cells by flow cytometry showed similar Y3P (Figure 2A) and M5/114, as well as mAbs that bind
levels of H2-M in wild-type and H2-Oa2/2 B cells (Figure to H2-Ab in a peptide-specific manner, such as BP107
1Da). In contrast, H2-Ob staining was barely detectable and KH74 (data not shown), stained H2-Oa2/2 and H2-
in the mutant cells (Figure 1Db). Oa1/1 cells equally well. In contrast H2-M±deficient mice
were weakly stained by KH74 and not at all by BP107, as
has been reported previously (Fung-Leung et al., 1996)Class II Expression in H2-Oa±Deficient Mice
In mice lacking H2-M, the cell surface levels of H2-Ab (data not shown). The staining with 30±2, a mAb which
specifically recognizes CLIP-H2-Ab complexes was veryare normal, but thepeptide content of thesemolecules is
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Figure 3. Antigen Presentation by B Cells
and Serum Immunoglobulin Levels
(A) Presentation of antigens internalized by
fluid phase to T cell hybridoma cells. Highly
purified B cells from H2±01/1 (circles) and
H2-O2/2 (triangles) mice were incubated with
0±800 mg/ml antigen (up to 400 mg/ml myo-
globin) and T hybridoma cells overnight. IL-2
production by the hybridoma cells was mea-
sured in culture supernatants by ELISA.
(B) Presentation of antigens internalized by
mIg-mediated uptake. B cells from transgenic
H2±01/1 (circles) and H2-O2/2 (triangles) mice
expressing anti-pc antibody were pulsed with
pc-conjugated antigens for 1 hr, washed ex-
tensively to remove the excess antigen, and
incubated with hybridoma cells overnight.
Values represent the mean (6 SD) IL-2 pro-
duction from triplicate cultures.
Levels of statistical significance between the
means using Student's t test are indicated
(*P , 0.05; ** P , 0.01; *** P , 0.005).
(C) Peptide presentation to HEL hybridoma
cells. B cells from H2-O1/1 (circles) and H2-
O2/2 (triangles) mice were cultured overnight
(18 hr) with 0±1 mM HEL peptide (amino acids
74±91) in the presence of the HEL hybridoma.
IL-2 production was measured as described
above.
weak on resting wild-type and H2-O2/2 B cells, while H2-Oa2/2 and H2-M2/2 mice; strong staining was ob-
served on medullary epithelial cells with weaker stainingH2-M2/2 B cells were stained well with this antibody.
Activation by treatment with LPS and IL-4 increased the on cortical epithelial cells (Surh et al., 1992; C. D. S.,
unpublished data). The stainings were specific, since30±2 staining on B cells from all three types of mice,
but there was still no difference in staining intensity binding of the antibodies was blocked in the presence
of the H2-Ob peptide used to raise the antiserum. Webetween wild-type and H2-Oa2/2 mice. MAb 15G4 also
recognizes CLIP-H2-Ab complexes but with higher affin- are presently investigating this finding.
Under mildly denaturing conditions, H2-Ab moleculesity than 30±2 (P. Wong and S. Y. Rudensky, manuscript
in preparation). The staining with this antibody also from both wild-type and H2-M±deficient mice migrate
as dimers on SDS±polyacrylamide gel electrophoresisshowed comparable CLIP-H2-Ab levels on lymph node
cells from wild-type and H2-Oa2/2 mice, whether the (SDS-PAGE) (Fung-Leung et al., 1996; Martinet al., 1996;
Miyazaki et al., 1996). The migration of the dimers is notcells were resting or had been activated, while the stain-
ing on cells from H2-M2/2 mice was very intense. The identical, however, and the finding that H2-Ab molecules
from H2-M±deficient mice are loaded almost exclusivelystaining increased on cells from all three types of mice
after activation (Figure 2A). with CLIP peptide explains this phenomenon. Analysis
of H2-Ab molecules immunoprecipitated from metaboli-Immunohistochemical analysis of the spleen and
lymph node from H2-Oa2/2 mice with an antiserum cally labeled H2-Oa1/1 or H2-Oa2/2 splenocytes using
mAb M5/114 showed that these molecules migratedagainst H2-Ob confirmed the absence of H2-O expres-
sion, which in wild type mice is limited mostly to B identically onSDS-PAGE, whether derived from thewild-
type or from the mutant cells, suggesting that the classcells (Figure 2B) (Wake and Flavell, 1985; Karlsson et
al., 1991). As expected from biochemical data (Liljedahl II molecules in H2-Oa2/2 mice contain a mixture of pep-
tides, like the class II molecules from wild-type miceet al., 1996), H2-O was undetectable in the spleen and
lymph node of H2-M2/2 mice, while H2-M expression (Figure 2C).
was normal in H2-Oa2/2 mice (Figure 2B). Unexpectedly,
however, the H2-Ob±specific antiserum gave staining Immune Functions in the Absence of H2-O
patterns identical to wild-type mice (Karlsson et al., The proportions of B cells as well as of CD41 and CD81
T cells in the lymph node, spleen, and thymus were1991; Surh et al., 1992) on thymic sections from both
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similar in H2-Oa±deficient and wild-type mice (data not or quantitatively. To investigate the molecular basis for
this phenomenon, recombinant soluble DO, DM, and DRshown). Lymph node CD41 T cells, which displayed a
naive phenotype when analyzed by CD44 and CD45RB, molecules as well as DMDO complexes were produced
in insect cells (Jackson et al., 1992; Matsumura et al.,reacted normally against allogenic stimulator cells. Like-
wise, we have been unable to find significant differences 1992). Human molecules rather than mouse molecules
were chosen, since DM function in vitro has been betterin the ability of spleen cells (depleted of T cells) from
mutant or wild-type mice to stimulate alloresponses characterized in the human system (Denzin and Cress-
well, 1995; Sloan et al., 1995; Weber et al., 1996; Krops-(data not shown). This finding is not unexpected, since
dendritic cells, which express little or no H2-O, are hofer et al., 1997). Both transmembrane and truncated
soluble forms of DO are unstable in the absence of DM,thought to be the main cell type mediating the response
in this assay (Sprent, 1995). B cells had normal surface and only minor amounts of DO exit the ER (Liljedahl
et al., 1996 and Figures 1B and 1C) To overcome thisexpression of IgM, IgD, CD5, CD16, CD19, CD22, CD23,
CD45R, and HSA (data not shown). problem, we fused the extracellular domains of DOA
and DOB to the Fc domain of human IgG1, thus creatingTo determine the capacity of B cells from H2-Oa2/2
mice to process and present protein antigens, B cells a DO±Fc fusion protein (below called DO). DMDO com-
plexes were isolated from cells expressing all four DMfrom wild-type and mutant mice were used to stimulate
IL-2 production from a panel of T cell hybridomas reac- and DO chains. Soluble DM and DR molecules were
generated as described in Experimental Procedures.tive with different antigens. Figure 3A shows that al-
though all the antigens could be presented by the wild- The activity of the recombinant DM and DMDO mole-
cules was tested for their ability to promote peptidetype cells to some extent after overnight incubation with
the antigen, hen egg lysozyme (HEL) and sperm whale loading of a fluorescent peptide from hemagglutinin (HA)
(amino acids 306±318) to DR1. At pH 5.5 the activity ofmyoglobin were distinctly better presented by the H2-
Oa2/2 B cells, while the difference for RNAse was smaller the recombinant molecules was found to be very similar
to what has been described for affinity-purified mole-(but seen consistently in several experiments). To evalu-
ate whether antigens internalized by mIg also were dif- cules from B cells (Denzin et al., 1997), confirming that
DO has an inhibitory effect on DM function (Figure 5A).ferentially presented, H2-Oa2/2 or wild-type litter-mates
were bred with 207-4 mice, carrying transgenes for DM can release peptides other than CLIP from class
II molecules (Weber et al., 1996; Kropshofer et al., 1997),phosphorylcholine (pc)±specific immunoglobulin m and
k chains. B cells from these mice were pulsed for 60 and the changed antigen presentation in the H2-Oa2/2
mice could be a reflection of changed specificity formin with pc-conjugated antigens and analyzed for their
ability to stimulate the same panel of hybridomas as peptide release of the H2-M±H2-O complexes com-
pared with H2-M alone. We analyzed the release of sev-mentioned above. In this situation, the presentation of
myoglobin by wild-type cells was superior to the presen- eral different peptides from DR1 in vitro (shown for CLIP
and HA in Figures 5B and 5C, respectively) but were nottation by the H2-Oa2/2±deficient cells, while HEL and
RNAse were presented equally well by the two types of able to find any differences in specificity between DMDO
and DM. In contrast, at pH 5.5, DMDO complexes con-presenting cells (Figure 3B). There was no difference in
the presentation between nonconjugated and pc-conju- sistently appeared to release peptides with slower kinet-
ics than DM alone.gated antigens when tested after fluid-phase uptake
(data not shown). B cells from mutant or wild-type mice
were equally efficient at presenting HEL peptide 74-91
DO Is a pH-Dependent Inhibitorto the HEL-reactive hybridoma (Figure 3C).
of DM FunctionThe increased presentation of antigens internalized
Alterations in pH often result in changed protein confor-by fluid-phase endocytosis could potentially lead to less
mation and changed protein function. To investigatestringent requirements for delivery of T cell help and
whether structural changes occurred in the purified pro-thus for the expansion of B cells. An indication that this
teins during acidification, we used the fluorescent probemay be the case was obtained when the serum levels
ANS (1-anilino-naphtalene-8-sulphonic acid). ANS fluo-of immunoglobulins were analyzed in nonimmunized
rescence is low in aqueous solutions but strongly in-(nontransgenic) mice. While young H2-Oa±deficient and
creased when the probe becomes associated withwild-type animals (6 weeks of age) had similar immuno-
exposed hydrophobic protein surfaces (Stryer, 1968;globulin levels of all subclasses (data not shown), older
Boniface et al., 1996; Runnels et al., 1996). While the ANSH2-Oa±deficient mice (10 months of age) had distinctly
fluorescence in samples containing DM alone did notincreased levels of IgG1 compared to the wild-type con-
increase significantly upon acidification (Figure 6A),trols (Figure 4). Other IgG subclasses and IgA did not
the fluorescence in DO and DMDO-containing samplesshow significant differences between the two types of
increased drastically, suggesting a change inDO confor-mice.
mation at lower pH. However, although DO may contrib-
ute most of the conformation change in the DMDO com-
plexes, it cannot be excluded that the conformation ofAnalysis of DM-DO Interaction In Vitro
The similar levels of CLIP-H2-Ab complexes in both wild- the associated DM molecules isalso altered. The confor-
mation change in DO-containing samples was indepen-type and mutant mice suggested that H2-O does not
effectively inhibit CLIP release in vivo, yet the changed dent of the DO Fc domain since the fluorescence of
CD27Fc did not increase at acidic pH. Incubation of DMpresentation of antigenic epitopes showed that H2-O
did influence peptide presentation, either qualitatively or DMDO complexes at the indicated pH for 4 hr did
Immunity
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Figure 4. Immunoglobulin Levels in Sera
Sera from 10-month-old sex-matched H2-
O1/1 (circles) and H2-O2/2 (triangles) mice
were titrated and immunoglobulin levels were
measured using isotype-specific ELISA. Bars
represent mean serum levels expressed as
optical density (OD) at 405 nm.
not further increase the ANS fluorescence (Figure 6B). To exclude the possibility that the Fc domain of DO
was influencing the function of the DMDO complexes,Neutralization of the samples containing DO restored
the original level of fluorescence, suggesting that the this domain was removed by papain digestion and the
capacity of the modified complex to catalyze peptideconformational changes were reversible.
DM is efficient in the pH range between 6 and 4.5 loading was analyzed. Figure 7B shows that the papain-
digested complexes, as well as DMDO complexes(although the optimal pH for peptide loading to class II
molecules is peptide and haplotype dependent) (Jen- formed in vitro from free DM and DO promoted peptide
loading with kinetics similar to those of the in vivo±sen, 1991; Denzin and Cresswell, 1995; Sherman et al.,
1995; Sloan et al., 1995). To determine whether the con- formed DMDO complexes, both at pH 5.5 and at pH 4.5.
At equilibrium, a certain amount of free DM is presentformational change in DO correlated with the capacity
for peptide exchange of DMDO complexes, peptide in the DMDO complex preparation (since the interaction
is noncovalent). To ascertain that the pool of free DMbinding to DR1 was analyzed at different pH levels in
the presence of equimolar amounts of DM or DMDO. present at neutral pH was not sufficient to mediate the
peptide loading we detected with the DMDO complexesWhile DM was found to catalyze loading of HA peptide
to DR1 throughout the expected pH range (in this case (if for example the DMDO complexes were irreversibly
destroyed), binding experiments were done at pH 5.5with optimal loading at pH 5.5), DMDO complexes were
inactive at higher pH but promoted peptide loading al- and pH 4.5 using DMDO complexes and two concentra-
tions of DM. Comparison of the loading kinetics showedmost as well as DM at pH 4.5 (Figure 7A). A similarly
increased activity of the DMDO complex at pH 4.5 com- that while the higher concentration of DM (64 nM) was
almost as effective as DMDO at pH 5.5 (Figure 7C),pared to pH 5.5 was seen for the loading of HLA-A2
peptide to DR1 and (to a smaller extent) for the associa- DMDO was distinctly better at the lower pH (Figure 7D),
suggesting either a release of more free active DM fromtion of a peptide from a mycobacterial heat shock pro-
tein (HSP 65) to DR3 (data not shown). the DMDO complexes upon acidification or a change in
Antigen Presentation in the Absence of H2-O
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Figure 6. Conformational Changes in DO and DMDO upon Acidifi-
cation
(A) Proteins (at 200 nM) were incubated at the indicated pH. ANS
(to 20 mM) was added and fluorescence was measured immediately.
(B) DM or DMDO (at 200 nM) were incubated at the indicated pH
for 4 hours at 378C. ANS (to 20 mM) was added and fluorescence was
measured immediately. Samples were neutralized and remeasured
immediately.
loading of peptides to class II molecules (i.e., H2-Ab) in
B cells, since protein antigens were presenteddifferently
to antigen-specific T cell hybridomas depending on
whether or not the presenting B cells expressed H2-Oa.
When the analyzed antigens were internalized by fluid-
phase endocytosis, all were presented better (to vary-
ing degrees) by B cells from H2-Oa±deficient mice than
by B cells from wild-type mice. In contrast, the same
antigens were either presented better or equally well
Figure 5. Analysis of DO Function In Vitro by B cells from wild-type mice when internalized by a
(A) Kinetics of FITC-HA binding to DR1. DR1 (500 nM) was incubated transgenic mIg, suggesting that the presence of H2-O
with FITC-HA peptide (2.5 mM) alone or with the indicated proteins results in discrimination between different forms of anti-
(DM 500 nM, DMDO 500 nM, or DM 500 nM and IgG1 500 nM) for gen uptake.
increasing lengths of time at 378C, pH 5.5. Samples were neutralized
The H2-Ab in H2-Oa±deficient mice appear to containand free peptide was separated from DR±peptide complexes by gel
a mixture of peptides and have essentially normal reac-filtration. A fluorescence of 100% represents the binding in the
tivity with anti-H2-Ab antibodies. Furthermore, the cellpresence of DM.
(B and C) Kinetics of FITC-CLIP (B) and FITC-HA (C) release from surface expression of CLIP-H2-Ab was found to be es-
DR1. DR1 preloaded with FITC-labeled peptides was incubated with sentially identical on both resting and activated B cells
5 mM unlabeled HA peptide alone or in the presence of DM (500 from wild-type or H2-Oa±deficient mice. This finding
nM) or DMDO (500 nM). Samples were treated as described above.
was somewhat unexpected, considering that Denzin etFluorescence is given as the percentage of the initial value.
al. (1997) have convincingly shown that expression of
DO inhibits DM-mediated CLIP release in transfected
cell lines, resulting in increased surface levels of CLIP±the DMDO complex that increased catalytic function at
the lower pH. class II complexes.
It is not obvious why expression of an additional mole-
cule inhibiting DM function would be more favorableDiscussion
than controlling the transcription of DM itself, unless
DO either changes the specificity of DM or provides aIn this study we used H2-Oa±deficient mice to address
the functional relevance of H2-O for antigen processing mechanism for more rapid shifts in DM activity than
can be achieved by transcriptional regulation. Cellularand presentation. We found that H2-O influences the
Immunity
240
Figure 7. Increased Activity of DMDO at Acidic pH
(A) CD27Fc, DM, or DMDO (125 nM) was incubated at 378C for 3 hr at the indicated pH before addition of DR1 (250 nM) and FITC-HA peptide
(5 mM). Samples were incubated for 1.5 hr at 378C and then neutralized and analyzed as in Figure 5. A fluorescence of 100% represents the
binding in the presence of DM at pH 5.5.
(B) Kinetics of FITC-HA binding to DR1 (500 nM) in the presence of CD27, DMDO, papain-digested DMDO, or in vitro±formed DMDO complexes
(DMDO mix), all at 500 nM. Samples were incubated for increasing lengths of time at 378C at pH 5.5 or pH 4.5 and then analyzed as in Figure
5. A fluorescence of 100% indicates the maximal fluorescence in the presence of DMDO at pH 4.5.
(C and D) Kinetics of FITC-HA binding to DR1 (500 nM) in the presence of CD27 (500 nM), DMDO (500 nM), and two dilutions of DM (64 nM
and 20 nM) at pH 5.5 (C) or pH 4.5 (D). Samples were incubated at and analyzed as described above. A fluorescence of 100% indicates the
maximal fluorescence in the presence of DMDO at pH 4.5.
activation or signal transduction eventscould potentially slower kinetics by DMDO than by DM, suggesting that
DO did not directly change the specificity of DM-medi-result in the dissociation of DMDO complexes, thus re-
leasing free DM. However, cross-linking of mIg on B ated peptide release.
An alternative explanation, supported by our bio-cell lines or splenocytes, as well as antigen-nonspecific
stimulation with LPS or phorbol esters, do not result chemical data, is that DO indirectly influences the speci-
ficity of DM-mediated peptide release by limiting the pHin readily detectable dissociation or posttranslational
modifications of DMDO (or H2-M±H2-O) complexes interval in which DM is fully active. Thus, while DM was
active in a relatively broad pH range, between pH 6.0(M. L. and L. K., unpublished data). Although we cannot
totally exclude such events, since transient or subtle and 4.5, the DMDO complexes had low activity at pH
greater than 5.5. At lower pH, however, the DMDO com-changes would be difficult to detect using standard bio-
chemical techniques, there is presently no evidence to plexes were almost as active as DM alone, suggesting
that association with DO decreases the pH optimum forsuggest that DM activity would be controlled by intracel-
lular signaling events. DM-mediated peptide exchange, or rather that associa-
tion with DO narrows the pH range where DM is active.The specificity of peptide loading could be changed
either directly or indirectly by the presence of DO/ It is not clear whether DMDO complexes dissociate at
acidic pH to release free active DM, or whether theH2-O. A possible direct effect was analyzed using puri-
fied recombinant molecules, and in this system we were complexes interact directly with DR molecules. We have
not been able to detectDR±DMDO complexes, butpres-able to confirm the previously published data (Denzin et
al., 1997) (obtained with detergent-solubilized material ently it cannot be excluded that they exist. It should be
pointed out that some free DM undoubtedly also existsfrom B cell lines) showing that DMDO complexes were
distinctly less active than DM alone in mediating CLIP in the endocytic pathway if DO is expressed, since the
two molecules are noncovalently associated.release. However, peptides other than CLIP also ap-
peared to be released from class II molecules with The pH-dependent differences in activity between DM
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Mannheim, Germany). H2-O was immunoprecipitated with a rabbitand DMDO complexes suggest that the differences in
antiserum (K535) against the H2-Ob cytoplasmic tail (Karlsson etantigen presentation observed between the H2-Oa±
al., 1991). H2-Ab was precipitated with M5/114 (Bhattacharya etdeficient and the wild-type mice may reflect a skewing
al., 1981). Immunoprecipitates were harvested with protein A- or
of the localization for peptide loading to more acidic G-Sepharose, washed, and resuspended in isoelectric focusing
compartments in the presence of H2-O. This could po- sample buffer (Figure 1B) (Jones, 1980) or SDS-PAGE sample buffer
containing 2% SDS without reduction. Samples were left at roomtentially result either in decreased or increased presen-
temperature for 20 min and then separated on 7.5%±12.5% poly-tation of a certain epitope, depending on where it be-
acrylamide gels directly or after nonequilibrium pH-gradient electro-comes accessible as well as how sensitive it is to
phoresis (pH 3.5±10). Gels were fixed, dried, and autoradiographed.destruction. The competition by other peptides for bind-
Autoradiographs were scanned using an Agfa Arcus II scanner.
ing to class II molecules will also influence the probabil- Composites were printed on a Kodak XLS 8600 printer.
ity of presentation of particular epitopes. In addition,
different class II molecules have varying pH require- Immunofluorescence
Cells were attached to coverslips coated with Cell-Tak (Collabora-ments for peptide loading, and this factor is also likely
tive Biomedical Research, Bedford, MA) before fixation with 4%to influence how they are affected by the presence or
formaldehyde±PBS. After fixation, cells were washed with 50 mMabsence of H2-O. Preferred peptide loading in lyso-
NH4Cl, PBS. Antibody incubations were made in PBS with 0.6%somes could be advantageous in the case of B cells, in fish skin gelatin and 0.2% saponin for permeabilization. Fluorescein
which relevant antigens are internalized by mIg (Rock isothiocyanate (FITC)±labeled anti-rabbit immunoglobulin (Cappel)
et al., 1984; Lanzavecchia, 1985). Protein domains are and Texas Red±labeled anti-mouse or anti-rat immunoglobulin (Mo-
lecular Probes) secondary reagents were used. Fluorescent cellsoften stabilized by their interaction with antibodies (Ac-
were imaged using a Bio-Rad confocal microscope.colla et al., 1981; Jemmerson and Paterson, 1986; Simit-
sek et al., 1995), and high-affinity antigen±antibody com-
Flow Cytometryplexes may require lysosomal conditions for the release
Lymph node and spleen cells were stained with biotinylated anti-
of antigenic epitopes, due to the protease resistance of IgM (m-specific) (Jackson ImmunoResearch), M5/114, Y3-P, 30±2,
the antibody itself. Decreased H2-M activity in endoso- BP107, KH74, B220, or J11d followed by FITC-streptavidin (Jackson
ImmunoResearch). For 15G4 (mouse IgG1), anti-IgG (Fcg-specificmal compartments (due to the association with H2-O)
F(ab9)2) was used for secondary staining. Cells were also double-would limit the risk of presenting antigens internalized by
stained with biotinylated anti-CD5, CD16, CD19, CD22, CD23, orfluid-phase or low-affinity receptors, without seriously
IgD followed by FITC-streptavidin and phycoerythrin (PE)±con-
limiting the presentation of antigens internalized by jugated anti-B220. Cells from lymph node and thymi were double-
high-affinity mIg. The elevated IgG1 titers in the H2- stained with FITC-conjugated anti-CD8 and PE-labeled anti-CD4 as
O±deficient mice may reflect increased activation of B previously described (Surh et al., 1992). For staining of permeabil-
ized cells, B cells were stained in 1% fetal calf serum with 0.1%cells in response to antigens taken up by fluid-phase
azide and 0.02% saponin without fixation using biotinylated K535or low-affinity receptors. During an immune response,
(anti-H2-Ob) or 2E5A (anti-H2-M) (Fung-Leung et al., 1996) followedactivation of CD41 T cells by B cells presenting pep-
by FITC-streptavidin.tides from such antigens could potentially result in the
expansion of T and B cells with irrelevant or harmful Immunohistochemistry
specificities. This could result in the dilution of an ef- Cryostat sections werestained for H2-O or H2-M with rabbit antisera
fective immune response, but also in the expansion of against the H2-Ob tail (K535) or against H2-M (K553) (Karlsson et
al., 1994), respectively, followed by biotinylated anti-rabbit IgGautoreactive cells, thus increasing the risk for auto-
(Jackson ImmunoResearch). Bound antibodies were detected withimmune reactions. The presence of H2-O/DO in B cells
alkaline phosphatase±conjugated streptavidin (Jackson Immuno-may thusserve to focus antigenpresentation to antigens
Research) and visualized with colorimetric substrate as described
internalized by mIg in order to increase the specificity (Surh et al., 1992).
of the immune response and to avoid reactivity to self
antigens. Antigen Presentation Assays
B cells were purified from pooled lymph node and spleen cells by
passage over G-10 columns and complement-mediated depletionExperimental Procedures
of T cells by antibodies directed against CD4 (RL 172) and CD8
(3.168), followed by a 90 min incubation on plastic tissue cultureGene Targeting
A 4.3 kb DNA fragment from a 129/Ola mouse genomic clone cov- dishes to remove any remaining adherent cells (Webb and Sprent,
1990). Purified B cells (1 3 105) were incubated in triplicate overnightering most of the H2-Oa gene was used in the knockout construct.
A cassette containing a neomycin-resistance gene was inserted into with 2 3 105 hybridoma cells recognizing sperm whale myoglobin
(HMb 4.2.2, kindly provided by P. Jensen, Emory University, Atlanta,exon 2. A herpes simplex±thymidine kinase cassette was placed at
the 39 end of the construct. The DNA construct was introduced into GA), HEL (BO4), and ribonuclease A (IB-E6) using increasing
amounts of relevant antigen or HEL peptide (amino acids 74±91).day 14 embryonic stem cells by electroporation. Cells were cultured
in the presence of 400 mg/ml G418 and 0.2 mM ganciclovir. Embry- Recombinant sperm whale myoglobin (Sigma), HEL, and ribo-
nuclease A (Calbiochem) were purchased. Cultured hybridoma su-onic stem cells with the targeted gene were detected by polymerase
chain reaction and then confirmed by Southern hybridization using pernatants were tested for the presence of IL-2 using ELISA ac-
cording to the manufacturer's instructions (Genzyme).DNA probes flanking the construct.
H2-Oa2/2 or H2-Oa1/1 mice were bred with transgenic 207-4 mice Receptor-mediated uptake and presentation to the panel of hy-
bridomas was studied after a 1 hr pulse with pc-conjugated antigens(Storb et al., 1986) (on a C57BL/6 background). Expression of the
transgene was tested with enzyme-linked immunosorbent assay (Gearhart et al., 1975), to B cells purified from 207-4 anti-pc
transgenic H2±01/1 orH2-O2/2 mice, followed by extensive washing.(ELISA) against pc-conjugated protein.
Data are shown as mean values 6 SD when indicated. Student's
t test was used to determine levels of significance between sampleMetabolic Labeling and Immunoprecipitation
Splenocytes were labeled with [35S]methionine and [35S]cysteine as means using Sigma plot 3.0 (Jandel).
None of the antigens is presented by antigen-presenting cellsindicated before lysis in 1% Triton X-100, phosphate-buffered saline
(PBS), and Complete proteinase inhibitor cocktail (Boehringer from H2-M2/2 mice (Martin et al., 1996; O. W., unpublished data).
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Peptides the members of the DNA core laboratory and peptide laboratories
for DNA sequencing and for oligonucleotide and peptide synthesis;Peptides were synthesized using F-moc chemistry. A fluorescein-
labeled lysine precursor was incorporated during synthesis of HA and M.Jackson, J. Sprent, R. Teasdale,and S. Webb for discussions
and comments.(306±318, sequence PKYVKQNTLKLAT). CLIP (81±104, sequence
LPKPPKPVSKMRMATPLLMQALPM) was labeled at the amino ter-
minus with FITC (Molecular Probes). Received December 3, 1997.
Typing of Antisera
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